TP53 and cancer: We have recently identified a drug-like compound (named hereafter Cpd12, Figure S1) endowed with antitumoral activity selective for HPV-transformed cancer cells as it binds and inhibits the viral oncoprotein E6 to rescue p53 protein levels [14].